封面
市場調查報告書
商品編碼
1517626

骨科影像設備市場規模 - 按產品類型(X 光、CT、MRI、超音波、EOS 影像系統)、適應症(創傷病例、運動傷害、脊椎損傷、關節炎、骨骼疾病、肌肉萎縮)、最終用途和預測, 2024 - 2032

Orthopedic Imaging Equipment Market Size - By Product Type (X-Ray, CT, MRI, Ultrasound, EOS Imaging System), Indication (Trauma Cases, Sport Injuries, Spinal Injuries, Arthritis, Bone Disorders, Muscle Atrophy), End-use & Forecast, 2024 - 2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 115 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

在人工智慧不斷融入以提高診斷準確性和效率的推動下,骨科成像設備市場規模從 2024 年到 2032 年的複合年成長率預計將達到 4.8%。該公司正在推出新的人工智慧整合設備,以改善影像分析和解釋,簡化工作流程,減少人為錯誤並提供個人化的治療計劃。

此外,人工智慧在輔助即時診斷和決策方面發揮著更重要的作用。骨科影像領域的持續發展使其更加精確、可靠且易於使用,這將有利於產品需求。例如,2022 年3 月,Pixee Medical 宣佈在美國推出Knee+ AR,這是其首款用於全膝關節置換術的擴增實境引導系統,同時透過創新的電腦輔助解決方案改進骨科成像設備,以提高手術精度。

該行業分為產品類型、適應症、最終用途和地區。

由於先進設備的更高整合度以改善患者護理,診斷影像中心最終用途領域的骨科影像設備市場佔有率將在 2024 年至 2032 年間實現可觀的成長率。這些中心採用最先進的技術,例如 MRI、CT 掃描和超音波來進行詳細的肌肉骨骼評估。他們也利用人工智慧驅動的工具來增強成像能力,以實現更精確、更快速的診斷。

就產品類型而言,預計超音波領域的骨科成像設備市場從2024年至2032年將出現顯著的複合年成長率。超音波技術擴大應用於骨科成像設備,以提供肌肉、肌腱和關節的即時動態影像。快速進步也增強了他們的診斷能力,以實現更準確和高效的評估。醫療保健提供者正在進一步將超音波解決方案納入其實踐中,透過非侵入性和無輻射成像來改善患者的治療結果。

在人口老化和對微創手術日益偏好的推動下,到 2032 年,亞太地區骨科影像設備產業規模將創下顯著的複合年成長率。亞太地區的醫療保健提供者正在擴大先進影像技術的使用,以滿足提高診斷精度和患者治療效果的需求。隨著需求的不斷成長,影像設備的不斷進步將支持採用微創技術來重塑骨科景觀,以確保該地區提供更好、更有效率的照護。

目錄

第 1 章:方法與範圍

第 2 章:執行摘要

第 3 章:產業洞察

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • 骨科疾病的發生率上升
      • 骨科成像領域的技術進步
      • 對早期疾病診斷的認知不斷提高
      • 微創手術的需求不斷增加
    • 產業陷阱與挑戰
      • 輻射暴露造成不良影響的風險
      • 設備成本高
  • 成長潛力分析
  • 技術景觀
  • 監管環境
  • 波特的分析
  • PESTEL分析

第 4 章:競爭格局

  • 介紹
  • 公司市佔率分析
  • 競爭定位矩陣
  • 戰略展望矩陣

第 5 章:市場估計與預測:按產品類型,2021 - 2032 年

  • 主要趨勢
  • X光系統
  • CT掃描儀
  • 核磁共振系統
  • EOS影像系統
  • 超音波
  • 核子造影系統

第 6 章:市場估計與預測:按指標分類,2021 - 2032 年

  • 主要趨勢
  • 外傷病例
  • 運動傷害
  • 脊椎損傷
  • 關節炎
  • 骨骼疾病
  • 肌肉骨骼癌
  • 肌肉萎縮
  • 其他適應症

第 7 章:市場估計與預測:按最終用途,2021 - 2032 年

  • 主要趨勢
  • 醫院
  • 診斷影像中心
  • 其他最終用戶

第 8 章:市場估計與預測:按地區,2021 - 2032

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區

第 9 章:公司簡介

  • Canon Inc.
  • Carestream Health
  • EOS imaging
  • Esaote SPA
  • FUJIFILM Holdings Corporation
  • GE HealthCare Technologies Inc.
  • Hologic, Inc.
  • Koninklijke Philips NV
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Shimadzu Corporation
  • Siemens Healthineers AG
簡介目錄
Product Code: 9157

Orthopedic Imaging Equipment Market size is set to record 4.8% CAGR from 2024 to 2032, driven by increasing incorporation of AI to enhance diagnostic accuracy and efficiency. Companies are launching new AI-integrated devices for improving image analysis and interpretation for streamlining workflows for reducing human error and providing personalized treatment plans.

In addition, AI is playing an even more significant role to assist in real-time diagnosis and decision-making. Such ongoing developments for transforming the orthopedic imaging field to make it more precise, reliable, and accessible will favor the product demand. For instance, in March 2022, Pixee Medical announced the U.S. launch of Knee+ AR, its first augmented reality guidance system for total knee arthroplasty while advancing orthopedic imaging equipment with innovative computer-assisted solutions for enhanced surgical precision.

The industry is segmented into product type, indication, end-use, and region.

Orthopedic imaging equipment market share from the diagnostic imaging centers end-use segment will record a decent growth rate between 2024 and 2032, due to higher integration of advanced devices to improve patient care. These centers are adopting state-of-the-art technologies, such as MRI, CT scans, and ultrasound for detailed musculoskeletal assessments. They are also enhancing their imaging capabilities with AI-driven tools for more precise and quicker diagnoses.

In terms of product type, the orthopedic imaging equipment market from the ultrasound segment is anticipated to witness a significant CAGR from 2024-2032. Ultrasound technology is increasingly utilized in orthopedic imaging equipment for providing real-time, dynamic images of muscles, tendons, and joints. Rapid advancements are also enhancing their diagnostic capabilities for enabling more accurate and efficient evaluations. Healthcare providers are further incorporating ultrasound solutions into their practices for improving patient outcomes with non-invasive and radiation-free imaging.

Asia Pacific orthopedic imaging equipment industry size will record notable CAGR through 2032, driven by the presence of an aging population and increasing preference for minimally invasive procedures. Healthcare providers in APAC are expanding the use of advanced imaging technologies to meet the needs for enhancing diagnostic precision and patient outcomes. As the demand is rising, the ongoing advancements in imaging equipment will support the adoption of minimally invasive techniques for reshaping the orthopedic landscape for ensuring better and more efficient care in the region.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360-degree synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising incidence of orthopedic disorders
      • 3.2.1.2 Technological advancement in the field orthopedic imaging
      • 3.2.1.3 Growing awareness regarding early disease diagnosis
      • 3.2.1.4 Increasing demand for minimally invasive procedures
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Risk of adverse effects from radiation exposure
      • 3.2.2.2 High cost of equipment
  • 3.3 Growth potential analysis
  • 3.4 Technological landscape
  • 3.5 Regulatory landscape
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Competitive positioning matrix
  • 4.4 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 X-ray system
  • 5.3 CT-scanner
  • 5.4 MRI system
  • 5.5 EOS imaging system
  • 5.6 Ultrasound
  • 5.7 Nuclear imaging system

Chapter 6 Market Estimates and Forecast, By Indication, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Trauma cases
  • 6.3 Sport injuries
  • 6.4 Spinal injuries
  • 6.5 Arthritis
  • 6.6 Bone disorders
  • 6.7 Musculoskeletal cancer
  • 6.8 Muscle atrophy
  • 6.9 Other indications

Chapter 7 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Hospitals
  • 7.3 Diagnostic imaging centers
  • 7.4 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Netherlands
    • 8.3.7 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
    • 8.5.4 Rest of Latin America
  • 8.6 Middle East and Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 South Africa
    • 8.6.3 UAE
    • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

  • 9.1 Canon Inc.
  • 9.2 Carestream Health
  • 9.3 EOS imaging
  • 9.4 Esaote SPA
  • 9.5 FUJIFILM Holdings Corporation
  • 9.6 GE HealthCare Technologies Inc.
  • 9.7 Hologic, Inc.
  • 9.8 Koninklijke Philips NV
  • 9.9 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 9.10 Shimadzu Corporation
  • 9.11 Siemens Healthineers AG